Found 0 matching trials
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
PHASE2Background:
Patients with cancers of the blood and immune system often ben...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
PHASE2This study evaluates the use of the standard treatment R-CHOP plus the anti...
Location
David Cunningham, Royal Marsden NHS Foundation Trust
Wound Necrosis in Lower Extremity Surgery
N/AResearchers are performing this study to evaluate if intraoperative angiogr...
Location
Mayo Clinic Rochester
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
PHASE1This study will be conducted to investigate the following:
1. The impact o...
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
PHASE2In this study the investigators investigate a cell therapy strategy that co...
Location
Masonic Cancer Center, University of Minnesota
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
PHASE3An open-label, controlled, randomized Phase 3 trial evaluating 12-month kid...
Location
University of Alabama at Birmingham (UAB) Hospital
Haploid Allogeneic Transplant Using the CliniMACS System
PHASE2To assess the proportion of patients with donor neutrophil engraftment with...
Location
Stanford University School of Medicine
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy
N/ARecently, the positive results of the Imbrave 150 study (randomized study c...
Location
Service hépato-gastroentérologie, Hôpital la Pitié-Salpêtrière
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
PHASE2The purpose of this study is to see if the combination of rituximab and ven...
Location
Beth Israel Deaconess Medical Center
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
PHASE3The aim of this study is to assess the efficacy of a rituximab regimen base...